Skip to main content
Top
Published in: Archives of Osteoporosis 1/2020

01-12-2020 | Bisphosphonate | Review

A case of pregnancy and lactation-associated osteoporosis and a review of the literature

Authors: Pu Jia, RuiDeng Wang, Jing Yuan, Hao Chen, Li Bao, Fei Feng, Hai Tang

Published in: Archives of Osteoporosis | Issue 1/2020

Login to get access

Abstract

Introduction

The pregnancy and lactation-associated osteoporosis (PLO) is a rare disease whose precise pathophysiological mechanisms remain mostly unknown.

Case report

We reported here a case of PLO that occurred in the early postpartum period and led to multiple compression fractures. Combination therapy with alendronate, calcium carbonate, and vitamin D was used to treat the patient and a marked but gradual increase in the density of bone mineral was observed. Moreover, no further fractures have occurred.

Conclusion

PLO is a very rare type of osteoporosis associated with severe chronic back pain. Increased bone resorption significantly increases the risk of bone fractures in women with PLO. Early diagnosis, stopping breastfeeding, treatment of calcium and vitamin D, bisphosphonates, or other antiosteoporosis medicine and regular follow-ups of these cases are particularly important in the prevention of fractures and to increase the quality of life of patients.
Literature
1.
go back to reference Kanis JA, Cooper C, Rizzoli R, Reginster JY (2018) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int Kanis JA, Cooper C, Rizzoli R, Reginster JY (2018) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int
2.
go back to reference Kuroda T, Nagai T, Ishikawa K, Inagaki K (2019) Clinical features and diagnosis of lumbar fractures caused by pregnancy- and lactation-associated osteoporosis. Clin Calcium 29:46–50PubMed Kuroda T, Nagai T, Ishikawa K, Inagaki K (2019) Clinical features and diagnosis of lumbar fractures caused by pregnancy- and lactation-associated osteoporosis. Clin Calcium 29:46–50PubMed
3.
go back to reference NORDIN BE, ROPER A (1955) Post-pregnancy osteoporosis; a syndrome? LANCET 268:431–434PubMed NORDIN BE, ROPER A (1955) Post-pregnancy osteoporosis; a syndrome? LANCET 268:431–434PubMed
4.
go back to reference Gehlen M, Lazarescu AD, Hinz C, Boncu B, Schmidt N, Pfeifer M, Schwarz-Eywill M, Pollahne W, Minne HW (2017) Pregnancy and lactation-associated osteoporosis. Z Rheumatol 76:274–278PubMed Gehlen M, Lazarescu AD, Hinz C, Boncu B, Schmidt N, Pfeifer M, Schwarz-Eywill M, Pollahne W, Minne HW (2017) Pregnancy and lactation-associated osteoporosis. Z Rheumatol 76:274–278PubMed
5.
go back to reference Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23:2735–2748PubMed Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23:2735–2748PubMed
6.
go back to reference Peris P, Guanabens N, Monegal A, Pons F, Martinez DOM, Ros I, Munoz-Gomez J (2002) Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 20:697–700PubMed Peris P, Guanabens N, Monegal A, Pons F, Martinez DOM, Ros I, Munoz-Gomez J (2002) Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 20:697–700PubMed
7.
go back to reference Winarno AS, Kyvernitakis I, Hadji P (2014) Successful treatment of 1-34 parathyroid hormone (PTH) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtshilfe Neonatol 218:171–173PubMed Winarno AS, Kyvernitakis I, Hadji P (2014) Successful treatment of 1-34 parathyroid hormone (PTH) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtshilfe Neonatol 218:171–173PubMed
8.
go back to reference Cook FJ, Mumm S, Whyte MP, Wenkert D (2014) Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res 29:922–928PubMed Cook FJ, Mumm S, Whyte MP, Wenkert D (2014) Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res 29:922–928PubMed
9.
go back to reference Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CC, Simon ME, Zillikens MC (2014) Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 99:1107–1111PubMed Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CC, Simon ME, Zillikens MC (2014) Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 99:1107–1111PubMed
10.
go back to reference Butscheidt S, Delsmann A, Rolvien T, Barvencik F, Al-Bughaili M, Mundlos S, Schinke T, Amling M, Kornak U, Oheim R (2018) Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int 29:1643–1651PubMed Butscheidt S, Delsmann A, Rolvien T, Barvencik F, Al-Bughaili M, Mundlos S, Schinke T, Amling M, Kornak U, Oheim R (2018) Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int 29:1643–1651PubMed
11.
go back to reference Kovacs CS (2014) Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94:1143–1218PubMed Kovacs CS (2014) Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94:1143–1218PubMed
12.
go back to reference Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin N Am 40:795–826 Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin N Am 40:795–826
13.
go back to reference Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832–872PubMed Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832–872PubMed
14.
go back to reference Eller-Vainicher C, Ossola MW, Beck-Peccoz P, Chiodini I (2012) PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur J Endocrinol 166:753–756PubMed Eller-Vainicher C, Ossola MW, Beck-Peccoz P, Chiodini I (2012) PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur J Endocrinol 166:753–756PubMed
15.
go back to reference Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26:2223–2241PubMed Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26:2223–2241PubMed
16.
go back to reference Trotter M, Hixon BB (1974) Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179:1–18PubMed Trotter M, Hixon BB (1974) Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179:1–18PubMed
17.
go back to reference Kovacs CS (2005) Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10:105–118PubMed Kovacs CS (2005) Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10:105–118PubMed
18.
go back to reference Wysolmerski JJ (2010) Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann N Y Acad Sci 1192:161–169PubMedPubMedCentral Wysolmerski JJ (2010) Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann N Y Acad Sci 1192:161–169PubMedPubMedCentral
19.
go back to reference Dobnig H, Kainer F, Stepan V, Winter R, Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G (1995) Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80:3699–3707PubMed Dobnig H, Kainer F, Stepan V, Winter R, Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G (1995) Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80:3699–3707PubMed
20.
go back to reference Stiegler C, Leb G, Kleinert R, Warnkross H, Ramschak-Schwarzer S, Lipp R, Clarici G, Krejs GJ, Dobnig H (1995) Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res 10:751–759PubMed Stiegler C, Leb G, Kleinert R, Warnkross H, Ramschak-Schwarzer S, Lipp R, Clarici G, Krejs GJ, Dobnig H (1995) Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res 10:751–759PubMed
21.
go back to reference Kovacs CS, Chik CL (1995) Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 80:3036–3042PubMed Kovacs CS, Chik CL (1995) Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 80:3036–3042PubMed
22.
go back to reference Rabbani SA, Khalili P, Arakelian A, Pizzi H, Chen G, Goltzman D (2005) Regulation of parathyroid hormone-related peptide by estradiol: effect on tumor growth and metastasis in vitro and in vivo. ENDOCRINOLOGY 146:2885–2894PubMed Rabbani SA, Khalili P, Arakelian A, Pizzi H, Chen G, Goltzman D (2005) Regulation of parathyroid hormone-related peptide by estradiol: effect on tumor growth and metastasis in vitro and in vivo. ENDOCRINOLOGY 146:2885–2894PubMed
23.
go back to reference Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I (2017) Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int 28:1393–1399PubMed Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I (2017) Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int 28:1393–1399PubMed
24.
go back to reference Ozturk G, Akpinar P, Karamanlioglu AD, Ozkan FU, Aktas I (2018) Pregnancy-related osteoporotic vertebral compression fractures in two patients treated with low-molecular-weight heparin during pregnancy: case reports. Gynecol Endocrinol 34:378–380PubMed Ozturk G, Akpinar P, Karamanlioglu AD, Ozkan FU, Aktas I (2018) Pregnancy-related osteoporotic vertebral compression fractures in two patients treated with low-molecular-weight heparin during pregnancy: case reports. Gynecol Endocrinol 34:378–380PubMed
25.
go back to reference Michalakis K, Peitsidis P, Ilias I (2011) Pregnancy- and lactation-associated osteoporosis: a narrative mini-review. Endocr Regul 45:43–47PubMed Michalakis K, Peitsidis P, Ilias I (2011) Pregnancy- and lactation-associated osteoporosis: a narrative mini-review. Endocr Regul 45:43–47PubMed
26.
go back to reference Nakamura Y, Kamimura M, Koiwai H, Kato H (2018) Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa. Ther Clin Risk Manag 14:945–948PubMedPubMedCentral Nakamura Y, Kamimura M, Koiwai H, Kato H (2018) Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa. Ther Clin Risk Manag 14:945–948PubMedPubMedCentral
27.
go back to reference Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H (2015) A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature. Ther Clin Risk Manag 11:1361–1365PubMedPubMedCentral Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H (2015) A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature. Ther Clin Risk Manag 11:1361–1365PubMedPubMedCentral
28.
go back to reference Zhang M, Chen P, Li B, Du J, Pan T, Chen J (2017) Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore) 96:e8671 Zhang M, Chen P, Li B, Du J, Pan T, Chen J (2017) Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore) 96:e8671
29.
go back to reference Holick MF (2007) Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 24:1017–1029PubMed Holick MF (2007) Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 24:1017–1029PubMed
30.
go back to reference Li L, Zhang J, Gao P, Lv F, Song Y, Chang X, Zhao D, Wang O, Jiang Y, Xing X, Xia W, Li M (2018) Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol 37:3141–3150PubMed Li L, Zhang J, Gao P, Lv F, Song Y, Chang X, Zhao D, Wang O, Jiang Y, Xing X, Xia W, Li M (2018) Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol 37:3141–3150PubMed
31.
go back to reference Grizzo FM, Da SMJ, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM (2015) Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int 97:421–425PubMed Grizzo FM, Da SMJ, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM (2015) Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int 97:421–425PubMed
32.
go back to reference Minsker DH, Manson JM, Peter CP (1993) Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121:217–223PubMed Minsker DH, Manson JM, Peter CP (1993) Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121:217–223PubMed
33.
go back to reference Ozturk C, Atamaz FC, Akkurt H, Akkoc Y (2014) Pregnancy-associated osteoporosis presenting severe vertebral fractures. J Obstet Gynaecol Res 40:288–292PubMed Ozturk C, Atamaz FC, Akkurt H, Akkoc Y (2014) Pregnancy-associated osteoporosis presenting severe vertebral fractures. J Obstet Gynaecol Res 40:288–292PubMed
34.
go back to reference Sun LM, Lin MC, Muo CH, Liang JA, Kao CH (2014) Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study. J Clin Endocrinol Metab 99:4259–4264PubMed Sun LM, Lin MC, Muo CH, Liang JA, Kao CH (2014) Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study. J Clin Endocrinol Metab 99:4259–4264PubMed
35.
go back to reference Sanchez A, Zanchetta MB, Danilowicz K (2016) Two cases of pregnancy- and lactation- associated osteoporosis successfully treated with denosumab. Clin Cases Miner Bone Metab 13:244–246PubMed Sanchez A, Zanchetta MB, Danilowicz K (2016) Two cases of pregnancy- and lactation- associated osteoporosis successfully treated with denosumab. Clin Cases Miner Bone Metab 13:244–246PubMed
36.
go back to reference Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H (2017) Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 56:863–866PubMed Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H (2017) Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 56:863–866PubMed
37.
go back to reference Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT (2014) Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. BONE 64:314–325PubMed Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT (2014) Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. BONE 64:314–325PubMed
38.
go back to reference Kostenuik PJ, Smith SY, Jolette J, Schroeder J, Pyrah I, Ominsky MS (2011) Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. BONE 49:151–161PubMed Kostenuik PJ, Smith SY, Jolette J, Schroeder J, Pyrah I, Ominsky MS (2011) Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. BONE 49:151–161PubMed
39.
go back to reference Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis. Hormones (Athens) 11:495–500 Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis. Hormones (Athens) 11:495–500
40.
go back to reference Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol 88:652–658 Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol 88:652–658
41.
go back to reference Coskun BI, Sarpel T, Guzel R (2014) Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol 34:736 Coskun BI, Sarpel T, Guzel R (2014) Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol 34:736
42.
go back to reference Yun KY, Han SE, Kim SC, Joo JK, Lee KS (2017) Pregnancy-related osteoporosis and spinal fractures. Obstet Gynecol Sci 60:133–137PubMedPubMedCentral Yun KY, Han SE, Kim SC, Joo JK, Lee KS (2017) Pregnancy-related osteoporosis and spinal fractures. Obstet Gynecol Sci 60:133–137PubMedPubMedCentral
43.
go back to reference Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y (2012) Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci 117:336–341PubMedPubMedCentral Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y (2012) Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci 117:336–341PubMedPubMedCentral
44.
go back to reference Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS (2009) Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J 9:e20–e24PubMed Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS (2009) Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J 9:e20–e24PubMed
45.
go back to reference Zarattini G, Buffoli P, Isabelli G, Marchese M (2014) Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate. Clin Cases Miner Bone Metab 11:139–141PubMedPubMedCentral Zarattini G, Buffoli P, Isabelli G, Marchese M (2014) Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate. Clin Cases Miner Bone Metab 11:139–141PubMedPubMedCentral
46.
go back to reference Abrahamsen B, Grove EL, Vestergaard P (2014) Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int 25:757–762PubMed Abrahamsen B, Grove EL, Vestergaard P (2014) Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int 25:757–762PubMed
47.
go back to reference Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S (2006) Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine 73:564–566PubMed Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S (2006) Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine 73:564–566PubMed
48.
go back to reference Kim HW, Song JW, Kwon A, Kim IH (2010) Percutaneous vertebroplasty for pregnancy-associated osteoporotic vertebral compression fractures. J Korean Neurosurg Soc 47:399–402PubMedPubMedCentral Kim HW, Song JW, Kwon A, Kim IH (2010) Percutaneous vertebroplasty for pregnancy-associated osteoporotic vertebral compression fractures. J Korean Neurosurg Soc 47:399–402PubMedPubMedCentral
49.
go back to reference Kezunovic M, Bulatovic N, Kadic V (2017) Bilateral subcapital femoral neck fracture in a 28 year old postpartum woman. Mediev Archaeol 71:151–153 Kezunovic M, Bulatovic N, Kadic V (2017) Bilateral subcapital femoral neck fracture in a 28 year old postpartum woman. Mediev Archaeol 71:151–153
50.
go back to reference Tsvetov G, Levy S, Benbassat C, Shraga-Slutzky I, Hirsch D (2014) Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women. MATURITAS 77:249–254PubMed Tsvetov G, Levy S, Benbassat C, Shraga-Slutzky I, Hirsch D (2014) Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women. MATURITAS 77:249–254PubMed
51.
go back to reference More C, Bhattoa HP, Bettembuk P, Balogh A (2003) The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover. Eur J Obstet Gynecol Reprod Biol 106:209–213PubMed More C, Bhattoa HP, Bettembuk P, Balogh A (2003) The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover. Eur J Obstet Gynecol Reprod Biol 106:209–213PubMed
52.
go back to reference Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 29:135–142PubMed Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 29:135–142PubMed
Metadata
Title
A case of pregnancy and lactation-associated osteoporosis and a review of the literature
Authors
Pu Jia
RuiDeng Wang
Jing Yuan
Hao Chen
Li Bao
Fei Feng
Hai Tang
Publication date
01-12-2020
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-00768-7

Other articles of this Issue 1/2020

Archives of Osteoporosis 1/2020 Go to the issue